Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482336.RAa8IO6BmQSc5ZjPzkTYtfwYK-dvTtE2m-dLnNAlyQ0PQ130_provenance.
• NP452483.RAt7q5X6GRw7xwjGbrgLwhx3s6ItPQwXcWXVVadLud6oY130_assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452483.RAt7q5X6GRw7xwjGbrgLwhx3s6ItPQwXcWXVVadLud6oY130_provenance.
• NP623927.RARTg-a5C90t8-sj6UytFMJVLcHcKDOa7Oam1_Stdj8lA130_assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623927.RARTg-a5C90t8-sj6UytFMJVLcHcKDOa7Oam1_Stdj8lA130_provenance.
• assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625067.RAr2L5_gwnDIg72Ycyr4z-dSaIUxiihpOZhufhSCnb2Uc130_provenance.
• NP986839.RAqf-DW8jaD28Rwd49_7CbR1v0jGaTqT_kG_ewXkbZgbE130_assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986839.RAqf-DW8jaD28Rwd49_7CbR1v0jGaTqT_kG_ewXkbZgbE130_provenance.
• NP621220.RA2WRx4wMp13-zjRdysAysv-_gZ4HUMGMtJjQ1ykYCO3c130_assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621220.RA2WRx4wMp13-zjRdysAysv-_gZ4HUMGMtJjQ1ykYCO3c130_provenance.
• NP622615.RA4k6h5C405ECfOQ2Un7qEsilLFOu7HeVyLvjuzlTnA6Y130_assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622615.RA4k6h5C405ECfOQ2Un7qEsilLFOu7HeVyLvjuzlTnA6Y130_provenance.
• NP986836.RA8asvAmkUfMtwxfZhuW7fKs-D55wS9lFOSfvIc38aNHY130_assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986836.RA8asvAmkUfMtwxfZhuW7fKs-D55wS9lFOSfvIc38aNHY130_provenance.
• NP986837.RA_BB0_ph8mtrDx3KTUctiDPn0ecjebj_2Xr619xaPWKk130_assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986837.RA_BB0_ph8mtrDx3KTUctiDPn0ecjebj_2Xr619xaPWKk130_provenance.
• NP986838.RA4xt5H_jcGLJt9cNoJtWFb05MvUQDeeno_0odhSMz0i0130_assertion description "[We suggest that TGF-? induces SREBP-2 pathway activation through ITGAV and PI3K playing a key role in OA and that integrin blockage may be a potential molecular target for OA treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986838.RA4xt5H_jcGLJt9cNoJtWFb05MvUQDeeno_0odhSMz0i0130_provenance.